Jump to start of content

Technical Support for those taking the Knowledge Check-In at home/in office Expand/Collapse the ABIM alert.

Technical assistance on the day of your Knowledge Check-In assessment is available by chatting with a Pearson VUE agent. We are here to help! You may also call 800-606-0259 to reach an ABIM Customer Relationship Advocate, in the event you are unable to connect to a Pearson VUE agent.

ABIM Scheduled Maintenance… Expand/Collapse the ABIM alert.

ABIM.org will be going through scheduled maintenance from 6 p.m. ET, Sat., 4/17/21 to 6 a.m. ET, Sun., 4/18/21. During this time, the ABIM Physician Portal will be unavailable. We apologize for any inconvenience this may cause. Thank you for your patience.

Coronavirus Updates Expand/Collapse the ABIM alert.

At ABIM we are actively monitoring the ongoing spread of coronavirus (COVID-19) and will post regular updates about any changes to scheduled assessments.
Scheduled for an assessment this year? ABIM is working with Pearson VUE to ensure your safety throughout your exam day. Learn more about what to expect at test centers.
Please follow the United States Centers for Disease Control and Prevention (CDC) for the most up-to-date information on the virus.

Breadcrumb trail:

Rheumatology Board Exam Committee

Expand All | Collapse All

Kenneth S. O'Rourke, MD, Chair

Kenneth S. O'Rourke, MD, ChairDr. O'Rourke, who is board certified in Internal Medicine and Rheumatology, is a Professor of Medicine at Wake Forest School of Medicine (WFSM). He is the Director of the Rheumatology Fellowship Training Program in the Section on Rheumatology and Immunology at WFSM (1995 to present).

Prior to his appointment at WFSM in 1992, Dr. O'Rourke was a lecturer in the Rheumatology Division of the Department of Internal Medicine at the University of Michigan (1991 to 1992). Prior to that position, he practiced general internal medicine in the United States Air Force (USAF) (1986 to 1989) and was the Program Director of the Transitional Year Residency at David Grant USAF Medical Center at Travis Air Force Base, California, while concurrently serving on the volunteer clinical faculty as Assistant Clinical Professor of Internal Medicine at the University of California, Davis (1987 to 1989).

Dr. O'Rourke is a fellow of the American College of Rheumatology (ACR) and member of the American College of Physicians. He is a member on the ACR's Curriculum Taskforce of the Committee on Education, and the Next Accreditation System Working Group of the Committee on Training and Workforce (COTW) that created the Rheumatology Entrustable Physician Activities and Rheumatology, Curricular Milestones. He currently serves as Chair of the American Board of Internal Medicine Rheumatology Board Exam Committee. He is a founding member of the Carolinas Fellows Collaborative, whose work has included the creation of a competency-based curriculum of goals, objectives and linked evaluations for rheumatology fellowship training programs. At WFSM, he has served on numerous education committees, including as Director of the second-year Musculoskeletal Block of the Systems Pathophysiology Course.

Dr O'Rourke obtained a bachelor's degree in bioengineering from the University of California, Berkeley. He trained in internal medicine at the David Grant USAF Medical Center and rheumatology training at the University of Michigan Medical Center.

As of August 2019, Dr. O’Rourke reported no ongoing external relationships.

Michael J. Battistone, MD

Michael J. Battistone, MDDr. Battistone, a board certified internist and rheumatologist, is Associate Professor (with tenure) of Medicine, in the Division of Rheumatology at the University of Utah. He is also the Director of the Center of Excellence in Musculoskeletal (MSK) Care and Education at the George E. Wahlen Veterans Affairs (VA) Medical Center in Salt Lake City, and co-Director of the National Musculoskeletal Training Programs at the VA Simulation, Learning, Education and Research Network (SimLEARN) in Orlando, Florida. He also supervises several internal medicine resident primary care clinics, and leads a multidisciplinary MSK clinic at the VA, which involves faculty from orthopedic, physical medicine and rehabilitation, and endocrinologic departments. Dr. Battistone is also the principal investigator at the Salt Lake City VA for the national Cooperative Studies Program STOP GOUT Trial.

Over the course of his career, he has served as the Director of the first, second and senior medical school courses in physical diagnosis; as Director of the core clerkship in internal medicine; and as Director of the rheumatology fellowship training program. He is a member of the American Board of Internal Medicine Rheumatology Board Exam Committee. Dr. Battistone has received numerous institutional teaching awards, as well as the national Clinician Scholar Educator award from the American College of Rheumatology Research Foundation.

Dr. Battistone received his medical degree from Duke University in 1991. He completed all his postgraduate training at the University of Utah Health Sciences Center, which included internal medicine internship and residency, an additional year as chief medical resident, and a two-year fellowship in rheumatology.

As of June 2019, Dr. Battistone reported the following external relationships.

Dr. Battistone serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Rheumatology, Member, Leader of Reproductive Health Initiative Core Team, receiving reimbursement for travel expenses.
  • Accreditation Council for Graduate Medical Education, Rheumatology Milestones 2.0 Taskforce Member, receiving reimbursement for travel expenses.

Dr. Battistone also reported that he is the site Principal Investigator for the Veterans Affairs Cooperative Studies Program study of comparative effectiveness in gout of allopurinol versus febuxostat, with funding provided to the Veterans Affairs.

Eliza Chakravarty, MD

Dr. Chakravarty is an Associate Member of the Oklahoma Medical Research Foundation, where she has an active clinical practice and a clinical research program focusing on pregnancy in women with autoimmune diseases. She is board certified in Rheumatology.

Previously, Dr. Chakravarty was an Assistant Professor of Medicine in the Division of Immunology at Stanford University School of Medicine in Palo Alto, California. During her time at Stanford, she served as Program Director for the Adult Rheumatology Fellowship program. Additionally, she served as an active member of the American College of Rheumatology Training and Workforce Committee. Currently, she serves as a member of the American Board of Internal Medicine Rheumatology Board Exam Committee.

Dr. Chakravarty received a bachelor's degree in chemistry and philosophy from New York University, a medical degree from the Johns Hopkins University and a master's degree in epidemiology from Stanford University. After completing internship, residency and Chief Residency in internal medicine at the Santa Clara Valley Medical Center in San Jose, California, she pursued fellowship training followed by an additional year of research training at Stanford University before joining the faculty in 2004.

As of August 2019, Dr. Chakravarty reported the following external relationships:

Teaching in satellite symposia funded by the following company, receiving honoraria:

  • UCB, for a video presentation of study results.

Other compensation from not-for-profit healthcare–related organization:

  • American College of Rheumatology, receiving consulting fees for participation in a Meet the Professor Session on "Difficult to Treat Lupus" annual scientific meeting.
  • National Institutes of Health, receiving salary support for an investigator-initiated multi-center study of mycophenolate mofeti withdrawal in stable lupus, funded through the Autoimmunity Centers of Excellence

Jennifer M. Grossman, MD

Jennifer M. Grossman, MDDr. Grossman is a Clinical Professor of Medicine in the Division of Rheumatology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). She is also the Director of Lupus Clinical Research at UCLA and serves as the educational coordinator for rheumatology in the internal medicine residency training program. She is board certified in Rheumatology.

Dr. Grossman is a member of the American Board of Internal Medicine Rheumatology Board Exam Committee. She is also a member of the American College of Rheumatology (ACR) and has served on the ACR Guidelines subcommittee. Dr. Grossman has been involved in quality of care measurements in osteoporosis and systemic lupus erythematosus. She is a member of the Lupus Foundation of America's scientific advisory board and is also a board member of Lupus LA.

Dr. Grossman received her bachelor's degree in chemistry from Williams College and her medical degree from the University of Rochester. She completed her internal medicine residency and rheumatology fellowship at the UCLA Center for the Health Sciences. She joined the faculty there in 1998.

As of May 2019, Dr. Grossman reported the following external relationships.

Funding for clinical trial expenses, salary support and staff, paid to University of California at Los Angeles, from the following companies:

  • AstraZeneca, for a Phase 3 study of anifrolumab for lupus, and for a long-term extension study of anifrolumab for moderate to severe lupus.
  • Eli Lilly & Company, for a randomized control trial of baracitinib in moderate to severe lupus.
  • Lupus Clinic Trials Consortium, for establishment of a long-term observational systemic lupus erythematosus database.

Dr. Grossman serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Lupus Foundation of America, Medical Scientific Advisory Board Member, without compensation.
  • Lupus LA, Medical Advisory Board Member, without compensation.

Funding for salary support, staff and expenses, paid to University of California at Los Angeles, from the following non-profit healthcare-related organizations:

  • Rheumatology Research Foundation, for a fellowship training grant.
  • National Institutes of Health, co-investigator on a colleague’s R01 grant studying cardiovascular disease in a lupus cohort, receiving salary support.

Hilary M. Haftel, MD

Hilary M. Haftel, MDDr. Haftel is Professor of Pediatrics, Internal Medicine and Health Learning Sciences at the University of Michigan Medical School, where she has spent her entire academic career. She is Director of the Division of Pediatric Rheumatology and leads the Adolescent and Young Adult Rheumatology Program. She has been the Associate Chair and Director of Education in the Department of Pediatrics and Communicable Diseases at the University of Michigan since 2007, after serving as Assistant and then Associate Director of Pediatric Education for 11 years. Dr. Haftel served as Director of Communication Skills and Professionalism at the University of Michigan Medical School from 2003 to 2007. She is board certified in Rheumatology and Pediatric Rheumatology.

Dr. Haftel is recognized nationally for her work in undergraduate and graduate medical education. She serves as a member of the American Board of Internal Medicine Rheumatology Board Exam Committee. She is a member of the Association for Pediatric Program Directors (APPD) Longitudinal Education Assessment Research Network (LEARN) Advisory Council and serves as its Chair. Dr. Haftel is Council Member of the APPD's Leadership in Educational Academic Development (LEAD) program. She has been named as a “Best Doctor in America” as well as being among “America's Best Pediatricians.”

Dr. Haftel received a bachelor's degree in biology and music from Union College in Schenectady, New York and a medical degree from Albany Medical College in Albany, New York, where she also completed residency training in combined medicine-pediatrics and a chief residency before coming to the University of Michigan for fellowship training in adult and pediatric rheumatology in 1991. Dr. Haftel received a master's of health professions education degree from the University of Illinois at Chicago in 2004.

As of September 2019, Dr. Haftel reported the following external relationships:

Dr. Haftel serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Academy of Pediatrics, Senior Vice President for Education, receiving salary support.

Joanne Valeriano-Marcet, MD

Joanne Valeriano-Marcet, MDDr. Valeriano-Marcet is board certified in Rheumatology and is Professor of Medicine at the University of South Florida, Morsani College of Medicine. Over the past 25 years, she has served in multiple capacities as clinician, educator, and leader in both graduate (GME) and undergraduate medical education (UME). She is on staff at Tampa General hospital, and the James A. Haley Veterans Hospital, and the University medical practice group, where she has outpatient rheumatology clinics, and performs inpatient consults. Dr. Valeriano-Marcet served as Chief of the Division of Rheumatology at the James A. Haley Veterans Hospital (2007-2014). She continues to practice rheumatology, mentor and provide inspiration to students, residents and fellows in the clinical setting. Dr. Valeriano maintains her certification as a clinical bone densitometrist and has extensive clinical experience in the area of osteoporosis.

Dr. Valeriano is the Rheumatology Program Director and has used the experience to continue to enhance her expertise in GME. At a national level, Dr. Valeriano was appointed member of the Next Accreditation System Working Group of the American College of Rheumatology (ACR) to develop the rheumatology entrustable professional activities, curricular milestones, and revision of the National ACR Curriculum published in June 2015. Her experience as co-Chair of the National Rheumatology In-Service Examination has been a valuable experience working with the National Board of Medical Examiners (NBME) in test development. Additionally, Dr. Valeriano-Marcet is a member of the American Board of Internal Medicine Rheumatology Board Exam Committee.

During the last 10 years, Dr. Valeriano also been involved in UME, including course development and instruction. Dr. Valeriano has developed extensive experience with using standardized patients in simulated patient scenarios, assessment and evaluation of clinical examinations. Her teaching career is marked by honors including; presenter of the white coats to first year medical students, Interprofessionalism Award from the University of South Florida School of Physical Therapy, and Outstanding Teacher Award from the University of South Florida, College of Medicine.

Dr. Valeriano received her bachelor’s degree from Cornell University and her medical degree from Cornell University Medical College in New York. She completed her internship and residency in internal medicine and her fellowship in rheumatology at Mount Sinai Medical Center, in New York.

As of February 2019, Dr. Valeriano-Marcet reported the following external relationships:

Dr. Valeriano-Marcet serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American College of Rheumatology, Resident Education Subcommittee Chair, without compensation.

Debendra Pattanaik, MD

Dr. Pattanaik, who is board certified in Internal Medicine, Rheumatology, Allergy and Immunology, is an Associate Professor (with tenure) of Medicine in the Division of Rheumatology at the University of Tennessee Health Science Center. He is the director of the Rheumatology Fellowship Program. He also serves as the Site Director of the Allergy and Immunology Fellowship Program at the VA Medical Center, Memphis TN.

Dr. Pattanaik is a fellow of the American College of Physicians, American College of Rheumatology (ACR) and American Academy of Allergy, Asthma and Immunology (AAAAI). During his career, he has served in the in-training examination (ITE) committee of ACR. He is also a member of ACR's Continuing Assessment Review Evaluation (CARE) program. He chairs the AAAAI VHA Allergist committee and is a member of the AAAA's Adverse Reactions to Drugs Biologicals & Latex Committee.

He serves on the board of directors of Tennessee Rheumatism Society. Dr. Pattanaik is currently a member of the American Board of Internal Medicine Rheumatology Board Exam Committee.

Dr. Pattanaik received his medical degree (MBBS) from SCB Medical College, Cuttack India. He finished residency in internal medicine at John H. Stroger, Jr. Hospital of Cook County, Chicago followed by fellowship in allergy and clinical immunology at University of Rochester Medical Center, New York NY and fellowship in rheumatology at University of Texas Health Sciences Center, San Antonio.

As of August 2019, Dr. Pattanaik reported the following external relationships:

Funding for clinical trial expenses and staff, paid to University of Tennessee Health Science Center, from the following companies:

  • Biogen, Principal Investigator for a Phase II clinical trial of lupus.
  • Bristol-Myers Squibb, Principal Investigator for a Phase II clinical trial of lupus.

Dr. Pattanaik serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Academy of Allergy, Asthma, and Immunology, Chair, VA Committee, without compensation.
  • Tennessee Rheumatism Society, Secretary, without compensation.

Avis Ware, MD

Dr. Ware is ABIM Board Certification in Rheumatology -2017-2027 (original certification in 1997); he is Professor of Medicine and Clinical Director of Rheumatology at the University of Cincinnati College of Medicine in Cincinnati, Ohio.

Dr. Ware obtained a bachelor's degree in music from Northwestern, University, Evanston Illinois, and his medical degree, from the University of Cincinnati College of Medicine. He completed his Internal Medicine Residency Training, from Christ Hospital in Cincinnati, OH. Dr. Ware had his fellowship training in Rheumatology at the University of Cincinnati College of Medicine and was the Program Director of the rheumatology training program at the University of Cincinnati College of Medicine.

As of August 2019, Dr. Ware reported no ongoing external relationships.